**Abstract**

***Objective:*** There are many studies examined brain structural changes in the hippocampus of major depressive disorder (MDD). However, only a few studies have focused on the results of hippocampal volumes and clinical severity of depressive symptoms. The hypothesis of this study was that if there is an association between hippocampal volume and clinical severity of depressive symptoms.

***Method:*** Forty-five patients with first-episode, drug-naïve MDD and 45 healthy controls with age- and gender- matched were recruited. All participants examined with 1.5T high-resolution magnetic resonance imaging. Longitudinal axis and subfields of hippocampus was analyzed by manual method and FreeSurfer, respectively. In addition, statistical parametric mapping (SPM) was used to identify associated volumetric changes. Analysis of covariance and partial correlation was used to compare the different volumes between MDD and HCs and their association of clinical severity of depressive symptoms, which was measured by using Montgomery Åsberg Depression Rating Scale.

***Results:*** The total hippocampal volume was significantly reduced in MDD compared with HCs (F=9.186, p=0.000). In the analysis of longitudinal axis, the hippocampal head (F=5.558, p=0.001) and body (F=4.643, p=0.002), but not tail (F=0.227, p=0.923) were significantly reduced in MDD. SPM with region-of--interest (ROI) analysis revealed that the gray-matter of right hippocampus (PFWE-correct=0.001) was significantly reduced. Results from the analysis of hippocampal subfields showed the reduction of areas included total Cornu Ammonis (CA) 2/3, subiculum, CA4/DG (Dentate Gyrus), presubiculum, hippocampus, CA1, and fimbria. No any other areas showed significantly changed. Importantly, the reduction of CA2/3 (r=-0.367, p=0.023), and CA4/DG (r=-0.403, p=0.012) areas were significantly correlated with the clinical severity of depressive symptoms.

***Conclusion:*** Our data indicate that the hippocampal volumes were reduced in patients with first-episode, drug-naïve MDD. The reduced hippocampal CA2/3 and CA4/DG, which were well correlated with the clinical severity of depressive symptoms, reflect the important role of these areas in the pathophysiology of MDD.
